Increased risk for developing gambling disorder under the treatment with pramipexole, ropinirole, and aripiprazole: A nationwide register study in Sweden

Gambling in patients with major depressive disorder is associated with an elevated risk of Suicide: Insights from 12-years of Nationwide inpatient sample data

(2021) Taranjeet Jolly et al.   ADDICTIVE BEHAVIORS

Gambling during the COVID-19 crisis - A cause for concern?

(2020) Anders Håkansson et al.   Journal of Addiction Medicine

Are All Dopamine Agonists Essentially the Same?

(2019) Margherita Torti et al.   DRUGS

Gambling disorder

(2019) Marc N. Potenza et al.   Nature Reviews Disease Primers

Common neurobiological and psychological underpinnings of gambling and substance-use disorders

(2019) Iris M. Balodis et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Dopaminergic signaling of uncertainty and the aetiology of gambling addiction

(2019) Martin Zack et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Increased Striatal Dopamine Synthesis Capacity in Gambling Addiction

(2018) Ruth J. van Holst et al.   BIOLOGICAL PSYCHIATRY

Comorbidities, treatment, and pathophysiology in restless legs syndrome

(2018) Claudia Trenkwalder et al.   LANCET NEUROLOGY

Neuroimaging of reward mechanisms in Gambling disorder: an integrative review

(2018) Luke Clark et al.   MOLECULAR PSYCHIATRY

Drug-induced gambling disorder: A not so rare but underreported condition

(2018) Pablo Figueroa Lanteri et al.   PSYCHIATRY RESEARCH

Gambling disorder, increased mortality, suicidality, and associated comorbidity: A longitudinal nationwide register study

(2018) Anna Karlsson et al.   Journal of Behavioral Addictions

Risk of Gambling Disorder and Impulse Control Disorder With Aripiprazole, Pramipexole, and Ropinirole

(2017) Mahyar Etminan et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

A Targeted Review of the Neurobiology and Genetics of Behavioural Addictions: An Emerging Area of Research

(2017) Robert F Leeman et al.   CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE

A European multicentre survey of impulse control behaviours in Parkinson's disease patients treated with short- and long-acting dopamine agonists

(2016) A. Rizos et al.   EUROPEAN JOURNAL OF NEUROLOGY

Pathological Gambling Associated With Aripiprazole or Dopamine Replacement Therapy

(2016) Marie Grall-Bronnec et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Problem gambling worldwide: An update and systematic review of empirical research (2000–2015)

(2016) Filipa Calado et al.   Journal of Behavioral Addictions

Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors

(2015) Philip Seeman   SYNAPSE

Unique Effects of Acute Aripiprazole Treatment on the Dopamine D2 Receptor Downstream cAMP-PKA and Akt-GSK3β Signalling Pathways in Rats

(2015) Bo Pan et al.   PLoS One

Drug safety evaluation of ropinirole prolonged release

(2014) Fabrizio Stocchi et al.   Expert Opinion On Drug Safety

Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study

(2014) P. J. Garcia-Ruiz et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Obsessive-Compulsive Aspects and Pathological Gambling in an Italian Sample

(2014) Filippo Petruccelli et al.   Biomed Research International

Neurobiology of gambling behaviors

(2013) Marc N Potenza   CURRENT OPINION IN NEUROBIOLOGY

A Single-Center, Cross-Sectional Prevalence Study of Impulse Control Disorders in Parkinson Disease

(2013) Michele Poletti et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling: a positron emission tomography study with [11C]-(+)-PHNO

(2013) I Boileau et al.   MOLECULAR PSYCHIATRY

Modafinil increases reward salience in a slot machine game in low and high impulsivity pathological gamblers

(2013) Kelly Smart et al.   NEUROPHARMACOLOGY

The D2/3dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride

(2012) Isabelle Boileau et al.   ADDICTION

Prevalence and Pharmacological Factors Associated With Impulse-Control Disorder Symptoms in Patients With Parkinson Disease

(2012) Santiago Perez-Lloret et al.   CLINICAL NEUROPHARMACOLOGY

Mesolimbic dopamine release is linked to symptom severity in pathological gambling

(2012) Juho Joutsa et al.   NEUROIMAGE

Striatal dopamine D2/D3 receptor binding in pathological gambling is correlated with mood-related impulsivity

(2012) Luke Clark et al.   NEUROIMAGE

Striatal dopamine release codes uncertainty in pathological gambling

(2012) Jakob Linnet et al.   PSYCHIATRY RESEARCH-NEUROIMAGING

Similarities and differences between pathological gambling and substance use disorders: a focus on impulsivity and compulsivity

(2011) Robert F. Leeman et al.   PSYCHOPHARMACOLOGY

Dopamine release in ventral striatum during Iowa Gambling Task performance is associated with increased excitement levels in pathological gambling

(2010) Jakob Linnet et al.   ADDICTION

Impulse Control Disorders in Parkinson Disease

(2010) Daniel Weintraub et al.   ARCHIVES OF NEUROLOGY

Olanzapine in the Treatment of Pathological Gambling

(2009) Susan L. McElroy et al.   JOURNAL OF CLINICAL PSYCHIATRY

Association between the dose of dopaminergic medication and the behavioral disturbances in Parkinson disease

(2009) Jee-Young Lee et al.   PARKINSONISM & RELATED DISORDERS

A double-blind, placebo-controlled trial of olanzapine for the treatment of video poker pathological gamblers

(2008) Timothy Fong et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

DSM-IV pathological gambling in the National Comorbidity Survey Replication

(2008) R. C. Kessler et al.   PSYCHOLOGICAL MEDICINE

Predictors of impulsivity and reward seeking behavior with dopamine agonists

(2007) William G. Ondo et al.   PARKINSONISM & RELATED DISORDERS